Role of nitric oxide in the regulation of intraocular pressure: a possibility for glaucoma treatment

References

• Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet22, 1711–1720 (2004).
   Google Scholar
• Bathija R, Gupta N, Zangwill L, Weinreb RN. Changing definition of glaucoma. J. Glaucoma7, 165–169 (1998).
   PubMed Web of Science ®Google Scholar
• McKinnon SJ, Goldberg LD, Peeples P, Walt JG, Bramley TJ. Current management of glaucoma and the need for complete therapy. Am. J. Manag. Care14, 20–27 (2008).
   PubMedGoogle Scholar
• Fechtner RD, Weinreb RN. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv. Ophthalmol.39, 23–42 (1994).
   PubMed Web of Science ®Google Scholar
• Flammer J. The vascular concept of glaucoma. Surv. Ophthalmol.38, S3–S6 (1994).
   PubMedGoogle Scholar
• Flammer J, Haefliger IO, Orgul S et al. Vascular dysregulation: a principal risk factor for glaucomatous damage?. J. Glaucoma8, 212–219 (1999).
   PubMed Web of Science ®Google Scholar
• Flammer J, Orgul S, Costa VP et al. The impact of ocular blood flow in glaucoma. Prog. Retin. Eye Res.21, 359–393 (2002).
   PubMed Web of Science ®Google Scholar
• Su WW, Cheng ST, Ho WJ, Tsay PK, Wu SC, Chang SHL. Glaucoma is associated with peripheral vascular endothelial dysfunction. Ophthalmology115, 1173–1178 (2008).
   PubMed Web of Science ®Google Scholar
• Resch H, Garhofer G, Fuchsjäger-Mayrl G, Hommer A, Schmetterer L. Endothelial dysfunction in glaucoma. Acta Ophthalmol.87, 4–12 (2009).
   PubMed Web of Science ®Google Scholar
• Jeganathan V, Wong T, Foster P et al. Peripheral artery disease and glaucoma. Arch. Ophthalmol.127, 888–893 (2009).
   PubMedGoogle Scholar
• Hulsman CA, Vingerling JR, Hofman A, Witteman JC, de Jong PT. Blood pressure, arterial stiffness, and open-angle glaucoma: the Rotterdam study. Arch. Ophthalmol.125, 805–812 (2007).
   PubMed Web of Science ®Google Scholar
• Guthauser U, Flammer J, Mahler F. The relationship between digital and ocular vasospasm. Graefes Arch. Clin. Exp. Ophthalmol.226, 224–226 (1988).
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Wisse M, Cursiefen S, Juneman A, Martus P, Korth M. Migraine and tension headache in high-pressure and normal-pressure glaucoma. Am. J. Ophthalmol.129, 102–104 (2000).
   PubMed Web of Science ®Google Scholar
• Logan JF, Chakravarthy U, Hughes AE, Patterson CC, Jackson JA, Rankin SJ. Evidence for association of endothelial nitric oxide synthase gene in subjects with glaucoma and history of migraine. Invest. Ophthalmol. Vis. Sci.46, 3221–3226 (2005).
   PubMed Web of Science ®Google Scholar
• Perlman JI, Delany CM, Sothern RB, Skolnick KA, Murray D, Jacobs RW. Relationships between 24h observations in intraocular pressure vs blood pressure, heart rate, nitric oxide and age in the medical chronobiology aging project. Clin.Ther.158, 31–47 (2007).
   Google Scholar
• Costa VP, Arcieri ES, Harris A. Blood pressure and glaucoma. Br. J. Ophthalmol.93, 1276–1282 (2009).
   PubMed Web of Science ®Google Scholar
• Ren R, Jonas JB, Tian G et al. Cerebrospinal fluid pressure in glaucoma: a prospective study. Ophthalmology117, 259–266 (2010).
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Moriya S, Oku H, Azuma I. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv. Ophthalmol.39, S49–S56 (1995).
   PubMed Web of Science ®Google Scholar
• Noske W, Hensen J, Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of patients with primary open angle glaucoma and cataract. Graefes Arch. Clin. Exp. Ophthalmol.235, 551–552 (1997).
   PubMed Web of Science ®Google Scholar
• Moncada S, Higgs A. The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol.14(Suppl. 1), S193–S201 (2006).
   Google Scholar
• Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem. J.357, 593–615 (2001).
   PubMed Web of Science ®Google Scholar
• Kotikoski H. Effects of nitric oxide donors and cyclic GMP on intraocular pressure and aqueous humor dynamics. PhD Thesis. University of Helsinki, Finland, 1–85 (2003).
   Google Scholar
• Haefliger IO, Dettmann E, Liu R et al. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv. Ophthalmol.43(Suppl. 1), S51–S58 (1999).
   PubMed Web of Science ®Google Scholar
• Chiou GCY. Review: effects of nitric oxide on eye diseases and their treatment. J. Ocul. Pharmacol. Ther.17, 189–198 (2001).
   PubMed Web of Science ®Google Scholar
• Meyer P, Champion C, Schlötzer-Schrehardt U, Flammer J, Haefliger IO. Localization of nitric oxide synthase isoforms in porcine ocular tissues. Curr. Eye Res.18, 375–380 (1999).
   PubMed Web of Science ®Google Scholar
• Becquet F, Courtois Y, Goureau O. Nitric oxide in the eye: multifaceted roles and diverse outcomes. Surv. Ophthalmol.42, 71–82 (1997).
   PubMed Web of Science ®Google Scholar
• Ellis D, Nathanson J. Nitric oxide in the human eye: sites of synthesis and physiologic actions on intraocular pressure, blood flow, sodium transport and neuronal viability. In: Nitric Oxide and Endothelin in Pathogenesis of Glaucoma. Haefliger IO, Flammer J (Eds). Lippincott-Raven Publishers, Philadelphia, PA, USA, Chapter 16, 178–204 (1998).
   Google Scholar
• Toda N, Nakanishi-Toda M. Nitric oxide: ocular blood flow, glaucoma and diabetic retinopathy. Prog. Retin. Eye Res.26, 205–238 (2007).
   PubMed Web of Science ®Google Scholar
• Neufeld AH, Kawai S-I, Das S et al. Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase. Exp. Eye Res.75, 521–528 (2002).
   PubMed Web of Science ®Google Scholar
• Tamm ER, Lütjen-Drecoll E. Nitric oxide in the outflow pathways of the aqueous humor. In: Nitric Oxide and Endothelin in Pathogenesis of Glaucoma. Haefliger IO, Flammer J (Eds). Lippincott-Raven Publishers, Philadelphia, PA, USA, Chapter 14, 158–167 (1998).
   Google Scholar
• Webb J, Yang X, Crosson C. Expression of the kallikrein/kinin system in human anterior segment. Exp. Eye Res.89, 126–132 (2009).
   PubMed Web of Science ®Google Scholar
• Schneemann A, Leusink-Muis A, van den Berg T, Hoyng PF, Kamphuis W. Elevation of nitric oxide production in human trabecular meshwork by increased pressure. Graefes Arch. Clin. Exp. Ophthalmol.241, 321–326 (2003).
   PubMed Web of Science ®Google Scholar
• Soltau JB, Zimmermann TJ. Changing paradigms in the medical treatment of glaucoma. Surv. Ophthalmol.47(Suppl. 1), S2–S5 (2002).
   PubMed Web of Science ®Google Scholar
• Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma?. Surv. Ophthalmol.52, S144–S154 (2007).
   PubMed Web of Science ®Google Scholar
• Millar JC, Shahidullah M, Wilson WS. Atriopeptin lowers aqueous humor formation and intraocular pressure and elevates ciliary cyclic GMP but lacks uveal vascular effects in the bovine perfused eye: J. Ocul. Pharmacol. Ther.13, 1–11 (1997).
   PubMed Web of Science ®Google Scholar
• Shahidullah M, Yap M, To CH. Cyclic GMP, sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye. Br. J. Pharmacol.145, 84–92 (2005).
   PubMed Web of Science ®Google Scholar
• Shahidullah M, Mandal A, Delamere N. Responses of sodium–hydrogen exchange to nitric oxide in porcine cultured nonpigmented ciliary epithelium. Invest. Ophthalmol. Vis. Sci.50, 5851–5858 (2009).
   PubMed Web of Science ®Google Scholar
• Motallebipour M, Rada-Iglesias A, Jansson M, Wadelius C. The promoter of inducible nitric oxide synthase implicated in glaucoma based genetic analysis and nuclear factor binding. Mol. Vis.11, 950–957 (2005).
   PubMed Web of Science ®Google Scholar
• Lee HK, Wang SC. Mechanism of morphine-induced miosis in the dog. J. Pharmacol. Exp. Ther.192, 415–431 (1975).
   PubMed Web of Science ®Google Scholar
• Bonfiglio V, Bucolo C, Drago F. Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits. Eur. J. Pharmacol.534, 227–232 (2006).
   PubMed Web of Science ®Google Scholar
• Dortch-Carnes J, Russel K. Morphine-induced nitric oxide production in isolated, iris–ciliary bodies. Exp. Eye Res.89, 660–664 (2009).
   PubMed Web of Science ®Google Scholar
• Stephano GB. The µ3 receptor subtype. Pain Forum8, 206–209 (1999).
   Web of Science ®Google Scholar
• Korenfeld MS, Becker B. Atrial natriuretic peptides. Effects on intraocular pressure, cGMP, and aqueous flow. Invest. Ophthalmol. Vis. Sci.30, 2385–2392 (1989).
   PubMed Web of Science ®Google Scholar
• Wiederholt M, Sturm A, Lepple-Wienues A. Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest. Ophthalmol. Vis. Sci.35, 2515–2529 (1994).
   PubMed Web of Science ®Google Scholar
• Nathanson JA. Atriopeptin activated guanylate cyclase in the anterior segment – identification, localization, and effects of atriopeptins on IOP. Invest. Ophthalmol. Vis. Sci.28, 1357–1364 (1987).
   PubMed Web of Science ®Google Scholar
• Kerr NM, Danesh-Meyer HV. Phosphodiesterase inhibitors and the eye. Clin. Experiment. Ophthalmol.37, 514–523 (2009).
   PubMed Web of Science ®Google Scholar
• Kotikoski H, Alajuuma P, Moilanen E et al. Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP. J. Ocul. Pharmacol. Ther.18, 11–23 (2002).
   PubMed Web of Science ®Google Scholar
• Behar-Cohen F, Goureau O, D’Hermies F, Courtois Y. Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye. Invest. Ophthalmol. Vis. Sci.37, 1711–1715 (1996).
   PubMed Web of Science ®Google Scholar
• Wolfensberger T, Singer D, Freegard T, Markandu N, Buckley M, MacGregor G. Evidence for new role of natriuretic peptide: control of intraocular pressure. Br. J. Ophthalmol.78, 446–448 (1994).
   PubMed Web of Science ®Google Scholar
• Kiel JW, Reitsamer HA, Walker JS, Kiel FW. Effects of nitric oxide synthase inhibition on ciliary blood flow, aqueous production and intraocular pressure. Exp. Eye Res.73, 355–364 (2001).
   PubMed Web of Science ®Google Scholar
• Fleischhauer JC, Liu R, Elena PP, Flammer J, Haefliger IO. Topical ocular instillation of nitric oxide synthase inhibitors and intraocular pressure in rabbits. Klin. Monbl. Augenheilkd.218, 351–353 (2001).
   PubMed Web of Science ®Google Scholar
• Giuffrida S, Bucolo C, Drago F. Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma. J. Ocul. Pharmacol. Ther.19, 527–534 (2003).
   PubMed Web of Science ®Google Scholar
• Vaajanen A. Expression and function of angiotensins in the regulation of intraocular pressure – an experimental study. PhD Thesis. University of Helsinki, Finland, 1–90 (2009).
   Google Scholar
• Vaajanen A, Luhtala S, Oksala O, Vapaatalo H. Does the renin–angiotensin system also regulate intraocular pressure?. Ann. Med.40, 418–427 (2008).
   PubMed Web of Science ®Google Scholar
• Brosnihan KB, Li P, Ferrario CM. Angiotensin (1–7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension27, 523–528 (1996).
   PubMed Web of Science ®Google Scholar
• Santos RAS, Campagnole-Santos MJ, Andrade SP. Angiotensin (1–7): an update. Regul. Peptides91, 787–790 (2000).
   Google Scholar
• Shah G, Sharma S, Mehta A, Goyal R. Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. J. Cardiovasc. Pharmacol.36, 169–175 (2000).
   PubMed Web of Science ®Google Scholar
• Wizemann AJ, Witzemann V. Organic nitrate therapy in glaucoma. Am. J. Ophthalmol.90, 106–109 (1980).
   PubMed Web of Science ®Google Scholar
• Iannaccone AE, DuPont J, Grunwald JE. Human retinal hemodynamics following administration of 5-isosorbide mononitrate. Curr. Eye Res.20, 205–210 (2000).
   PubMed Web of Science ®Google Scholar
• Diestelhorst M, Hinzpeter B, Kriegelstein GK. The effect of isosorbide-mononitrate eye drops on the human intraocular pressure and aqueous humor dynamics. Int. Ophthalmol.15, 259–262 (1991).
   PubMed Web of Science ®Google Scholar
• Diestelhorst M, Kriegelstein GK. The intraocular response of human atrial natriuretic factor in glaucoma. Int. Ophthalmol.13, 99–101 (1989).
   PubMed Web of Science ®Google Scholar
• Garhöfer G, Resch H, Lung S, Weigert G, Schmetterer L. Intravenous administration of L-arginine increases retinal and choroidal blood flow. Am. J. Ophthalmol.140, 69–76 (2005).
   PubMed Web of Science ®Google Scholar
• Schmidl D, Polska E, Kiss B, Sacu S, Garhofer G, Schmetterer L. Ocular hemodynamic effects of nitrovasodilators in healthy subjects. Clin. Pharmacol. Ther.87, 87–92 (2010).
   PubMed Web of Science ®Google Scholar
• Kotikoski H, Moilanen E, Vapaatalo H, Aine E. Biochemical markers of the L-arginine–nitric oxide pathway in the aqueous humor in glaucoma patients. Acta Ophthalmol. Scand.80, 191–195 (2002).
   PubMedGoogle Scholar
• Gulaia NM, Zhaboedov GD, Petrenko OV, Kurilina EI, Kosiakova GV, Berdyshev AG. Changes of nitric oxide level at different stages of primary open-angle glaucoma. Ukr. Biokhim. Zh.75, 85–89 (2003).
   Google Scholar
• Galassi F, Renieri G, Sodi A, Ucci F, Vannozzi L, Masini E. Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma. Br. J. Ophthalmol.88, 757–760 (2004).
   PubMed Web of Science ®Google Scholar
• Simader C, Lung S, Weigert G et al. Role of NO in the control of choroidal blood flow during a decrease in ocular perfusion pressure. Invest. Ophthalmol. Vis. Sci.50, 372–377 (2009).
   PubMed Web of Science ®Google Scholar
• Fernández-Durango R, Fernández-Martinez A, Garcia-Feijoo J et al. Expression of nitrotyrosine and oxidative consequences in the trabecular meshwork of patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci.49, 2506–2511 (2008).
   PubMed Web of Science ®Google Scholar
• Aslan M, Cort A, Yucel I. Oxidative and nitrative stress markers in glaucoma. Free Radic. Biol. Med.45, 367–376 (2008).
   PubMed Web of Science ®Google Scholar
• Henry E, Newby DE, Webb DJ, O´Brien C. Peripheral endothelial dysfunction in normal pressure glaucoma. Invest. Ophthalmol. Vis. Sci40, 1710–1714 (1999).
   PubMed Web of Science ®Google Scholar
• Buckley C, Hadoke PW, Henry E, O´Brien C. Systemic vascular endothelial cell dysfunction in normal pressure glaucoma. Br. J. Ophthalmol.86, 227–232 (2002).
   PubMed Web of Science ®Google Scholar
• Parantainen, J, Vapaatalo H, Hokkanen E. Relevance of prostaglandins in migraine. Cephalalgia5(Suppl. 2), 93–97 (1985).
   PubMed Web of Science ®Google Scholar
• Kang JH, Wiggs JL, Rosner BA et al. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use. Invest. Ophthalmol. Vis. Sci51, 971–979 (2010).
   PubMed Web of Science ®Google Scholar
• Cleary C, Buckley C, Henry E, McLoughlin P, O’Brien C, Hadoke P. Enhanced endothelium derived hyperpolarizing factor activity in resistance arteries from normal pressure glaucoma patients: implications for vascular function in the eye. Br. J. Ophthalmol.89, 223–228 (2005).
   PubMed Web of Science ®Google Scholar
• Dismuke WM, Mbadugha CC, Ellis DZ. NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel. Am. J. Physiol. Cell Physiol.294, 1378–1386 (2008).
   PubMed Web of Science ®Google Scholar
• Werne A, Harris A, Moore D, BenZion I, Siesky B. The circadian variations in systemic blood pressure, ocular perfusion pressure, and ocular blood flow: risk factors for glaucoma. Surv. Ophthalmol.53, 559–567 (2008).
   PubMed Web of Science ®Google Scholar
• Polak K, Luksch A, Berisha F, Fuchsjaeger-Mayrl G, Dallinger S, Schmetterer L. Altered nitric oxide system in patients with open-angle glaucoma. Arch. Ophthalmol.125, 494–498 (2007).
   PubMedGoogle Scholar
• Nguyen TT, Kreis AJ, Kawasaki R et al. Reproducibility of the retinal vascular response to flicker light in Asians. Curr. Eye Res.34, 1028–1088 (2009).
   Google Scholar
• Mandecka A, Dawczynski J, Vilser W et al. Abnormal retinal autoregulation is detected by provoked stimulation with flicker light in well-controlled patients with Type 1 diabetes without retinopathy. Diabetes Res. Pract.86, 51–55 (2009).
   PubMed Web of Science ®Google Scholar
• Pemp B, Garhofer G, Weigert G et al. Reduced retinal vessel response to flicker light stimulation but not to exogenous nitric oxide in Type 1 diabetes. Invest. Ophthalmol. Vis. Sci.50, 4029–4032 (2009).
   PubMed Web of Science ®Google Scholar
• Kanno M, Araie M, Koibuchi H, Masuda K. Effect of topical nipradilol, a b blocking agent with a blocking and nitroglecerin-like activities, on intraocular pressure and aqueous dynamics in humans. Br. J. Ophthalmol.84, 293–299 (2000).
   PubMed Web of Science ®Google Scholar
• Kanno M, Araie M, Masuda K et al. Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Arzneimittelforschung56, 729–734 (2006).
   PubMed Web of Science ®Google Scholar
• Karim MZ, Sawada A, Mizuno K, Kawakami H Ishida K, Yamamoto T. Neuroprotective effect of nipradilol [3,4-dihydro-8(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration. J. Glaucoma18, 26–31 (2009).
   PubMed Web of Science ®Google Scholar
• Steele RM, Benedini F, Biondi S et al. Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open angle glaucoma. Bioorg. Med. Chem. Lett.19, 6565–6570 (2009).
   PubMed Web of Science ®Google Scholar
• Carreiro S, Anderson S, Gukasyan H, Krauss A, Prasanna G. Correlation of in vitro and in vivo kinetics of nitric oxide donors in ocular tissues. J. Pharmacol. Ther.25, 105–112 (2009).
   Google Scholar
• Galassi F, Masini E, Giambene B et al. A topical nitric oxide-releasing dexamethasone derivative: effects on intraocular pressure and ocular haemodynamics in a rabbit glaucoma model. Br. J. Ophthalmol.90, 1414–1419 (2006).
   PubMed Web of Science ®Google Scholar
• Wallace JL, Viappiani S, Bolla M. Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis. Trends Pharmacol. Sci.30, 112–117 (2009).
   PubMed Web of Science ®Google Scholar
• Oresmaa L, Kotikoski H, Haukka M et al. Synthesis and ocular effects of imidazole nitrolic acid and amidoxime esters. Bioorg. Med. Chem. Lett.16, 2144–2147 (2006).
   PubMed Web of Science ®Google Scholar
• Perrino E, Uliva C, Lanzi C, Del Soldato P, Masini E, Sparatore A. New prostaglandin derivative for glaucoma treatment. Bioorg. Med. Chem. Lett.19, 1639–1642 (2009).
   PubMed Web of Science ®Google Scholar
• Borghi V, Bastia E, Guzzetta M et al. A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog and primate models of glaucoma. J. Ocul. Pharmacol. Ther.26, 125–132 (2010).
   PubMed Web of Science ®Google Scholar
• Vannacci A, Marzocca C, Giannini L et al. Evaluation of the effects of a novel carbon monoxide releasing molecule (CORM-3) in an in vitro model of cardiovascular inflammation. 1. Histamine in allergy, inflammation, tissue growth and repair. Inflamm. Res.55, S05–S06 (2006).
   Google Scholar
• Feelisch M. The use of nitric oxide donors in pharmacological studies. Naunyn. Schmiedebergs Arch. Pharmacol.358, 113–122 (1998).
   PubMed Web of Science ®Google Scholar
• Glasser SP. Prospects for therapy of nitrate tolerance. Lancet353, 1545–1546 (1999).
   PubMed Web of Science ®Google Scholar
• Münzel T, Harrison DG. Evidence for a role of oxygen-derived free radicals and protein kinase C in nitrate tolerance. J. Mol. Med.75, 891–900 (1997).
   PubMed Web of Science ®Google Scholar
• Schwemmer M, Bassenge E. New approaches to overcome tolerance to nitrates. Cardiovasc. Drugs Ther.17, 159–173 (2003).
   PubMed Web of Science ®Google Scholar